• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ERIKA DE REYNOSA, S.A. DE C.V. COMBI SET; SET, TUBING, BLOOD, WITH AND WITHOUT ANTI-REGURGITATION VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ERIKA DE REYNOSA, S.A. DE C.V. COMBI SET; SET, TUBING, BLOOD, WITH AND WITHOUT ANTI-REGURGITATION VALVE Back to Search Results
Model Number 03-2622-3
Medical Device Problem Code Fluid/Blood Leak (1250)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 03/17/2023
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
The plant investigation is in process.A supplemental mdr will be submitted upon completion of this activity. .
 
Event or Problem Description
It was reported to fresenius that a crack was identified in the venous chamber of the combiset bloodlines during a patient's hemodialysis (hd) treatment.There was blood loss as a result of the reported issue.The patient's estimated blood loss (ebl) was not provided.There was no adverse event or required medical intervention reported.The patient continued treatment after the bloodlines were replaced.The sample is not available to be returned to the manufacturer for physical evaluation.Additional information was requested however a response has not been received.
 
Event or Problem Description
It was reported to fresenius that a crack was identified in the venous chamber of the combiset bloodlines during a patient's hemodialysis (hd) treatment.There was blood loss as a result of the reported issue.Additional information was obtained during follow-up.The reported event occurred approximately 10 minutes after treatment initiation.The reported issue was visually observed.There was no serious injury or required medical intervention as a result of the reported issue.The patient's estimated blood loss (ebl) was not provided.The blood within the circuitry was returned.The patient completed treatment on the same machine with new supplies.The sample has been discarded and is not available to be returned to the manufacturer for physical evaluation.
 
Additional Manufacturer Narrative
Plant investigation: as the device was not returned to the manufacturer, a physical evaluation could not be performed.A batch records review was conducted by the manufacturer for the reported lot.There were no non-conformances or abnormalities identified during the manufacturing process which could be associated with the reported event.The entire lot has been sold and distributed.In addition, a device history review was performed and confirmed that the results of the in-progress and final quality control (qc) testing met all requirements.The lot met all specifications for release.A product history review did not reveal a probable cause for the customer complaint.As a physical evaluation could not be performed, a definitive conclusion regarding the reported incident could not be reached and a cause could not be confirmed.
 
Event or Problem Description
It was reported to fresenius that a crack was identified in the venous chamber of the combiset bloodlines during a patient's hemodialysis (hd) treatment.There was blood loss as a result of the reported issue.Additional information was obtained during follow-up.The reported event occurred approximately 10 minutes after treatment initiation.The reported issue was visually observed.There was no serious injury or required medical intervention as a result of the reported issue.The patient's estimated blood loss (ebl) was not provided.The blood within the circuitry was returned.The patient completed treatment on the same machine with new supplies.The sample has been discarded and is not available to be returned to the manufacturer for physical evaluation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COMBI SET
Common Device Name
SET, TUBING, BLOOD, WITH AND WITHOUT ANTI-REGURGITATION VALVE
Manufacturer (Section D)
ERIKA DE REYNOSA, S.A. DE C.V.
mike allen #1331
parque industrial reynosa
reynosa 88780
MX  88780
Manufacturer (Section G)
ERIKA DE REYNOSA, S.A. DE C.V.
director, quality systems
900 w zaragosa drive suite d
pharr TX 78577
Manufacturer Contact
jessica trujillo
920 winter st
waltham, MA 02451
6174175172
MDR Report Key16702043
Report Number0008030665-2023-00344
Device Sequence Number17585706
Product Code FJK
UDI-Device Identifier00840861100231
UDI-Public00840861100231
Combination Product (Y/N)N
Initial Reporter CountryMX
PMA/510(K) Number
K962081
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,User Facility
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup,Followup
Report Date (Section B) 05/01/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date07/31/2025
Device Model Number03-2622-3
Device Catalogue Number03-2622-3
Device Lot Number22JR01016
Was Device Available for Evaluation? No
Device AgeMO
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 03/30/2023
Supplement Date Received by Manufacturer04/12/2023
04/28/2023
Initial Report FDA Received Date04/07/2023
Supplement Report FDA Received Date04/27/2023
05/01/2023
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured07/03/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexMale
-
-